Company news

Find out what’s going on within Adelphi Values, from new interesting people making a difference to updates on our latest work.

Cheryl Coon, Associate Director from our Endpoint Development & Outcomes Assessment practice will be presenting at the DIA 2014 50th Annual Meeting in San Diego on June 19th. The session titled ‘Moving Beyond the Traditional Psychometric Validation of New Phase 3 Clinical Outcome Assessments’ will be on June 19, 9:00AM… Read More

We are delighted to report that on February 18 2014, Chelsea Therapeutics announced that the US Food and Drug Administration (FDA) granted accelerated approval of NortheraTM (Droxidopa) for the treatment of symptomatic neurogenic hypotension (NOH).  Not only is this the first new treatment for NOH in nearly… Read More

On July 29th Adelphi Values will move to Atlantic Wharf – a building recognized last year as Boston’s first ‘green’ skyscraper.  The 1.2 million square-foot mixed-use project made the headlines in 2012 when Boston Properties received the Global Award for Excellence from the Urban Land Institute for the restored historic… Read More

To meet the evolving needs of our clients, Adelphi Values has recruited two additional Directors with extensive experience of working in the EU, US and Asian payer environments. This further increases the capability to help our clients address the needs of public and private payers at the local and national… Read More

As part of an initiative to increase patient involvement within regulatory decisions (set by Obama in 2012), on April 24 2013 the FDA launched a new patient website called FDA Patient Network Launched with the slogan: ‘Get Informed. Get Involved. Help FDA Help Patients Have a Bigger Voice’ the new… Read More